Marcus Capital, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 194 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
Marcus Capital, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$183,000
-27.1%
10,825
-15.6%
0.58%
-37.1%
Q1 2018$251,000
-15.8%
12,825
-12.8%
0.92%
-18.9%
Q4 2017$298,00014,7001.14%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Third Security, LLC 19,816,162$191,226,0008.73%
BB BIOTECH AG 6,825,532$65,866,0002.13%
Lombard Odier Asset Management (USA) Corp 2,700,000$26,055,0001.79%
SECTORAL ASSET MANAGEMENT INC 3,724,351$35,940,0001.61%
QVT Financial LP 2,010,186$19,398,0000.97%
JHL Capital Group LLC 1,475,000$14,234,0000.94%
MAZAMA CAPITAL MANAGEMENT INC 358,087$3,456,0000.79%
EcoR1 Capital, LLC 160,700$1,551,0000.78%
Alden Global Capital Ltd 332,500$3,209,0000.77%
IRIDIAN ASSET MANAGEMENT LLC/CT 7,274,065$70,195,0000.65%
View complete list of HALOZYME THERAPEUTICS INC shareholders